HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab.

AuthorsSoon Thye Lim, Nancy Rubin, Jonathan Said, Alexandra M Levine
JournalAnnals of hematology (Ann Hematol) Vol. 84 Issue 8 Pg. 551-2 (Aug 2005) ISSN: 0939-5555 [Print] Germany
PMID15800785 (Publication Type: Letter)
Chemical References
  • Anti-Retroviral Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
Topics
  • Anti-Retroviral Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Herpesvirus 8, Human (isolation & purification)
  • Humans
  • Lymphoma (drug therapy, pathology, virology)
  • Lymphoma, AIDS-Related (diagnosis, drug therapy)
  • Lymphoma, Large B-Cell, Diffuse (diagnosis, drug therapy)
  • Male
  • Middle Aged
  • Neoplasms, Second Primary (diagnosis, drug therapy)
  • Pericardial Effusion (pathology)
  • Pleural Effusion, Malignant (diagnosis, drug therapy, virology)
  • Remission Induction
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: